Abstract
Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayr, B., Pötter, E., Goretzki, P. et al. Expression of Ret/PTC1, -2, -3, -Δ3 and -4 in German papillary thyroid carcinoma. Br J Cancer 77, 903–906 (1998). https://doi.org/10.1038/bjc.1998.149
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.149
- Springer Nature Limited
This article is cited by
-
Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study
Thyroid Research (2023)
-
RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations
Pathology & Oncology Research (2020)
-
Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters
Tumor Biology (2014)
-
Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma
Laboratory Investigation (2004)
-
Familial isolated parathyroid adenoma in a consanguineous family
Journal of Endocrinological Investigation (2001)